ClinicalTrials.Veeva

Menu

Lidocaine Infusion Versus Magnesium Infusion in Decreasing Fentanyl Requirements in Endoscopic Sinus Surgeries

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Not yet enrolling
Phase 4

Conditions

Perioperative Pain
Enhanced Recovery
Magnesium Sulphate
Lidocaine
Functional Endoscopic Sinus Surgery

Treatments

Drug: Magnesium group
Drug: Lidocaine group
Drug: Control group

Study type

Interventional

Funder types

Other

Identifiers

NCT06966102
MS-15-2025

Details and patient eligibility

About

Enhanced recovery after ear, nose and throat surgery is based on multimodal and multidisciplinary perioperative interventions to decrease postoperative pain. Functional endoscopic sinus surgery is a surgical management for chronic rhinosinusitis. Although a common procedure, there is a lack of knowledge about perioperative pain and specific pain management after such a procedure. Most of recommendations given in guidelines for postoperative pain management in nasal surgery and sinus surgery are subsumed under head and neck surgery. Head and neck surgery is a wide field covering widely variable surgical procedures. So, postoperative pain management guidelines may not meet the requirements for pain management during and after endoscopic sinus surgery.

Various medications have been used to improve the surgical field and postoperative pain including intravenous clonidine, dexmedetomidine, lidocaine, and magnesium.

Lidocaine has been used considering its analgesic, immuno-modulating, and anti-inflammatory properties. The opioid sparing effect of lidocaine is supported by a high level of evidence. The effectiveness of lidocaine infusion in obtaining reduction of postoperative pain, gastrointestinal recovery time, postoperative nausea and vomiting, and shortening the hospital length of stay, was demonstrated principally in major gastro-intestinal surgery.

Magnesium sulfate is a good option in multimodal analgesia, as it stabilizes the cell membrane and intracytoplasmic organelles by mediating the activation of Na+-K+ ATPase and Ca++ ATPase enzymes, which have an important role in transmembrane ion exchange during the depolarization and repolarization phases. Moreover, magnesium inhibits the release of norepinephrine by blocking the N-type Ca++ channels at nerve endings.

Many studies were designed to prove the role of the analgesic effect of lidocaine and magnesium infusion. However, this is the first randomized controlled study to assess the effect of lidocaine infusion versus magnesium sulphate infusion on decreasing total fentanyl requirements in patients undergoing functional endoscopic sinus surgery.

This randomized controlled trial was designed to compare the efficacy of lidocaine hydrochloride infusion versus magnesium sulphate infusion in controlling perioperative pain in patients undergoing functional endoscopic sinus surgery.

Enrollment

156 estimated patients

Sex

All

Ages

21 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age from 21 to 60 years.
  • Both genders.
  • American society of Anesthesiologist (ASA) physical status I-II
  • Scheduled for functional endoscopic sinus surgery under general anesthesia.

Exclusion criteria

  • Patients with prolonged QT interval.
  • Patients with renal disease.
  • Patients with a history of allergy to lidocaine or magnesium sulfate.
  • American Society of Anesthesiologists class higher than II.
  • Patient refusal

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

156 participants in 3 patient groups

Group L
Active Comparator group
Description:
Patients received 2 mg/kg/h lidocaine hydrocloride starting at induction of anesthesia and continuing until the end of surgery
Treatment:
Drug: Lidocaine group
Group M
Active Comparator group
Description:
Patients received magnesium sulphate 20 mg/kg/h starting at induction of anesthesia and continuing until the end of surgery
Treatment:
Drug: Magnesium group
Group C
Sham Comparator group
Description:
Patients received saline infusion starting at induction of anesthesia and continuing until the end of surgery
Treatment:
Drug: Control group

Trial contacts and locations

1

Loading...

Central trial contact

Kareem MA Nawwar, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems